Skip to main content
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 7, 2006

Articles

TGF Beta Inhibition for Cancer Therapy
pp. 565-578(14)
Authors: Saunier, Elise F.; Akhurst, Rosemary J.

Favourites:
ADD
Favourites:
ADD

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models
pp. 603-612(10)
Authors: Hengstler, J. G.; Bockamp, E. O.; Hermes, M.; Brulport, M.; Bauer, A.; Schormann, W.; Schiffer, I. B.; Hausherr, C.; Eshkind, L.; Antunes, C.; Franzen, A.; Krishnamurthi, K.; Lausch, E.; snm, R.Lessig; Chakrabarti, T.; Prawitt, D.; Zabel, B.; Spangenberg, C.

Favourites:
ADD

Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention
pp. 613-622(10)
Authors: Chen, Xiaoxin; Sood, Sandeep; Yang, Chung S.; Li, Ning; Sun, Zheng

Favourites:
ADD

Protein Kinases as Drug Targets in Cancer
pp. 623-634(12)
Authors: Arslan, Mehmet Alper; Kutuk, Ozgur; Basaga, Huveyda

Favourites:
ADD

Adrenomedullin: A Tumor Progression Factor via Angiogenic Control
pp. 635-643(9)
Authors: Nakamura, Misa; Han, Bo; Nunobiki, Osamu; Kakudo, Kennichi

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content